27-Jul-2026
Download PDF
Senores Pharmaceuticals
Senores Pharmaceuticals Limited has informed the Exchange regarding submission of statement of deviation or variation in utilisation of funds raised through preferential issue of convertible equity warrants for the quarter ended on June 30 2026.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
